ID: ALA2397331

Max Phase: Preclinical

Molecular Formula: C15H27N3O2

Molecular Weight: 281.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCn1cc(CCCCCCCCCCC(=O)O)nn1

Standard InChI:  InChI=1S/C15H27N3O2/c1-2-18-13-14(16-17-18)11-9-7-5-3-4-6-8-10-12-15(19)20/h13H,2-12H2,1H3,(H,19,20)

Standard InChI Key:  GBQHPFBOIBIINV-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 281.40Molecular Weight (Monoisotopic): 281.2103AlogP: 3.44#Rotatable Bonds: 12
Polar Surface Area: 68.01Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.95CX Basic pKa: 0.50CX LogP: 3.89CX LogD: 1.47
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.60Np Likeness Score: -0.69

References

1. Marshall AJ, Lin JM, Grey A, Reid IR, Cornish J, Denny WA..  (2013)  Long-chain triazolyl acids as inhibitors of osteoclastogenesis.,  21  (14): [PMID:23726411] [10.1016/j.bmc.2013.05.013]

Source